Oric Pharmaceuticals Statistics
NASDAQ: ORICHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.36-0.34 (-4.42%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Oric Pharmaceuticals by the numbers
Oric Pharmaceuticals has a market capitalization of $764.9 million based on 103.93M shares outstanding. With trailing EPS of $-1.44, Oric Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 33.6% below its 50-day average and 32.6% below its 200-day average.
Average daily trading volume is 1.59M shares, or about $11.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ORIC valuation vs. peer median
| Metric | ORIC | Peer median | Difference |
|---|---|---|---|
| Market cap | $764.94M | $761.54M | +0% |
| Avg. volume | 1.59M | 2.28M | -30% |
Peer median across 8 companies: COLL, RIGL, IRWD, ARDX, IVA, SNDX, OBX, VSTM.
Valuation
- Market cap
- $764.94M
- EPS (TTM)
- $-1.44
- Shares outstanding
- 103.93M
Price and trading
- Previous close
- 7.70
- Open
- 7.58
- Day range
- 7.28 – 8.00
- 52-week range
- 7.23 – 14.68
- 52-week change
- -36.66%
- Beta
- —
- Volume
- 1.46M
- Average volume
- 1.59M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 16, 2026
Additional statistics
- Market Cap
- 764.94M
- Forward Pe
- -4.21
- Eps
- -1.44
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 14.68
- Week52 Low
- 7.23
- Avg Volume
- 1.59M
- Shares Outstanding
- 103.93M
- Ma50
- 11.08
- Ma200
- 10.92
- Earnings Date
- Nov 16, 2026
- Pct From52w High
- -49.86%
- Pct From52w Low
- 1.80%